Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Globus Medical's quarterly finished goods
increased
from Dec. 2025 (MXN9,589 Mil) to Mar. 2026 (MXN9,721 Mil) and
increased
from Mar. 2026 (MXN9,721 Mil) to Jun. 2026 (MXN9,800 Mil).
Globus Medical's annual finished goods
declined
from Dec. 2023 (MXN12,009 Mil) to Dec. 2024 (MXN10,250 Mil) and
declined
from Dec. 2024 (MXN10,250 Mil) to Dec. 2025 (MXN9,589 Mil).
Globus Medical Inventories, Finished Goods Historical Data
* Premium members only.
The historical data trend for Globus Medical's Inventories, Finished Goods can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Inventories, Finished Goods of MXN9,800 Mil mean?
Globus Medical (MEX:GMED) has a Inventories, Finished Goods of MXN9,800 Mil as of Jun. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Globus Medical and its competitors.
Is Globus Medical's Inventories, Finished Goods too high?
Globus Medical's current Inventories, Finished Goods is MXN9,800 Mil. Overall, Globus Medical has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's Inventories, Finished Goods compare to PODD and BRKR?
Globus Medical's Inventories, Finished Goods of MXN9,800 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Devices & Instruments company?
A good Inventories, Finished Goods depends on the Medical Devices & Instruments industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Globus Medical and its competitors. Globus Medical's current Inventories, Finished Goods is MXN9,800 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (MEX:GMED) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,696.39, compared to a current price of MXN1,390.45 — trading 18% below its estimated fair value. The current Inventories, Finished Goods is MXN9,800 Mil. Globus Medical's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Globus Medical (MEX:GMED), the current Inventories, Finished Goods is MXN9,800 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Globus Medical (MEX:GMED) Overvalued in 2026?
Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued.
The current stock price of MXN1,390.45 is trading 18% below its estimated GF Value™ of MXN1,696.39.
GuruFocus considers Globus Medical to be Modestly Undervalued.
Key valuation signals for MEX:GMED:
Inventories, Finished Goods: MXN9,800 Mil
GF Value™: MXN1,696.39 vs. price of MXN1,390.45 (18% below fair value)
No single metric tells the full story. See the MEX:GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
92GF Score
Get the complete analysis for MEX:GMED
Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GMED has been successfully added to your 
